Opening book details…
Can I read Multi-omics analysis uncovers tumor ecosystem dynamics during neoadjuvant toripalimab plus nab-paclitaxel and S-1 for esophageal squamous cell carcinoma: a single-center, open-label, single-arm phase 2 trial on EtoBox?
Multi-omics analysis uncovers tumor ecosystem dynamics during neoadjuvant toripalimab plus nab-paclitaxel and S-1 for esophageal squamous cell carcinoma: a single-center, open-label, single-arm phase 2 trial by Guoqing Zhang; Jing Yuan; Chaohu Pan; Qing Xu; Xiaoli Cui; Jing Zhang; Minglu Liu; Zhigang Song; Liangliang Wu; Dongfang Wu; Haitao Luo; Yi Hu; Shunchang Jiao; Bo Yang is a Medicine article available to read on EtoBox.
What is Multi-omics analysis uncovers tumor ecosystem dynamics during neoadjuvant toripalimab plus nab-paclitaxel and S-1 for esophageal squamous cell carcinoma: a single-center, open-label, single-arm phase 2 trial about?
## Summary ## Background Immune checkpoint inhibitors combined with chemotherapy as a neoadjuvant therapy have been applied to the treatment of esophageal squamous cell carcinoma (ESCC). However, the optimal regimen needs to be further explored, particularly for older patients, and the mechanisms by which the immune checkpoint inhibitor combined with chemotherapy modulates the evolution of ESCC are unknown. ## Methods In this single-arm phase 2 trial, patients with resectable (stage II/III/IV without metastasis) ESCC were enrolled and received nanoparticle albumin-bound (nab) paclitaxel for two cycles and oral S-1 for 2 weeks, combined with intravenous toripalimab for two cycles before surgery. Combination postoperative adjuvant therapy was administered. The primary outcome was the major pathological response (MPR). Secondary outcomes included pathological complete response (pCR), overall response rate (ORR), disease control rate (DCR), disease-free survival (DFS), overall survival (OS), improvement in Stooler's dysphagia score and degree of daily living ability (dADL). Biopsies and plasma pre- and post-neoadjuvant therapy were performed using whole-exome sequencing, transcriptome
Who reads Multi-omics analysis uncovers tumor ecosystem dynamics during neoadjuvant toripalimab plus nab-paclitaxel and S-1 for esophageal squamous cell carcinoma: a single-center, open-label, single-arm phase 2 trial?
It is typically read by researchers, students, and practitioners in Medicine.
- Author
- Guoqing Zhang; Jing Yuan; Chaohu Pan; Qing Xu; Xiaoli Cui; Jing Zhang; Minglu Liu; Zhigang Song; Liangliang Wu; Dongfang Wu; Haitao Luo; Yi Hu; Shunchang Jiao; Bo Yang
- Publisher
- Elsevier
- Published
- 2023
- Language
- EN
- Field
- Medicine (Life Sciences)